Plasma phospholipid fatty acids in obese male and female mexican children

Annals of Nutrition and Metabolism

Volumn 57, Issue 3-4, 2011, Pages 234-241

  Elizondo Montemayor, Leticia ^a   Serrano González, Mónica ^a   Ugalde Casas, Patricia A ^a   Cuello García, Carlos ^b   Borbolla Escoboza, José R ^c  

^a Clinical Research Center   (Mexico)

^b The Evidence Based Medicine Department   (Mexico)

^c SCHOOL OF ENGINEERING AND SCIENCES   (Mexico)

Author keywords

Children fatty acids; Obesity; Polyunsaturated fatty acids

Indexed keywords

FATTY ACID; MONOUNSATURATED FATTY ACID; SATURATED FATTY ACID; UNSATURATED FATTY ACID;

ARTICLE; BODY FAT; BODY MASS; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHILD; CHILDHOOD OBESITY; DISEASE PREDISPOSITION; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; INSULIN RESISTANCE; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; MEXICO; OBESITY; PRIORITY JOURNAL; SEX DIFFERENCE; SKINFOLD; TRICEPS BRACHII MUSCLE; WAIST CIRCUMFERENCE;

BODY MASS INDEX; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHILD; FATTY ACIDS; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; MALE; MEXICO; OBESITY; PHOSPHOLIPIDS; RISK FACTORS; SEX FACTORS; SKINFOLD THICKNESS; WAIST CIRCUMFERENCE;

EID: 78649762937     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000322626     Document Type: Article

References (47)

1. México avanza en la cobertura universal de salud: Felipe Calderón. México Sano. Mexico City, Secretaría de Salud, 2009.
2. Weiss R, Dziura J, Burgert TS, et al: Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 2362-2374.
3. Valle M, Gascon F, Martos R, et al: Metabolic cardiovascular syndrome in obese prepubertal children: the role of high fasting insulin levels. Metabolism 2000; 51: 423-428.
4. De Onis M, Blosner M: Prevalence and trends of overweight among preschool children in developing countries. Am J Clin Nutr 2000; 72: 1032-1039.
5. Ebbeling CB, Pawlak DB, Ludwing DS: Childhood obesity: public-health crisis, common sense cure. Lancet 2002; 360: 473-482.
6. Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J: The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb 2005; 12: 295-300.
7. Decsi T, Molnar D, Koletzko B: Long-chain polyunsaturated fatty acids in plasma lipids of obese children. Lipids 1996; 31: 305-311.
8. Decsi T, Molnár D, Koletzko B: Lipids, polyunsaturated fatty acids and lipid soluble vitamins in obese children. Pediatr Wspótczesna Gastroenterol Hepatol 1999; 1,2/3: 109-113.
9. Haslam DW, James WP: Obesity. Lancet 2005; 366: 1197-1209.
10. Phinney SD, Davis PG, Johnson SB, Holman RT: Obesity and weight loss alter serum polyunsaturated lipids in humans. Am J Clin Nutr 1991; 53: 831-838.
11. Vessby B: Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr Opin Lipidol 2003; 14: 15-19.
12. Decsi T, Csabi G, Torok K, et al: Polyunsaturated fatty acids in plasma lipids of obese children with and without metabolic cardiovascular syndrome. Lipids 2000; 35: 1179-1184.
13. Klein-Platat C, Drai J, Oujaa M, Schlienger JL, Simon C: Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. Am J Clin Nutr 2005; 82: 1178-1184.
14. Decsi T, Molnar D, Koletzko B: The effect of under- and overnutrition on essential fatty acid metabolism in childhood. Eur J Clin Nutr 1998; 52: 541-548.
15. Scaglioni S, Verduci E, Salvioni M, et al: Plasma long-chain fatty acids and the degree of obesity in Italian children. Acta Paediatr 2006; 95: 964-969.
16. Gil-Campos M, Ramírez-Tortosa M, Larqué E, et al: Metabolic syndrome affects fatty acid composition of plasma lipids in obese prepubertal children. Lipids 2008; 43: 723-732.
17. Vessby B, Gustafsson IB, Tengblad S, Boberg M, Andersson A: Desaturation and elongation of fatty acids and insulin action. Ann NY Acad Sci 2002; 967: 183-195.
18. Rajala MW, Scherer PE: Minireview: the adipocyte - at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 2003; 144: 3765-3773.
19. Delarue J, Lefoll C, Corporeaua C, Lucas D: N-3 long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity? Reprod Nutr Dev 2004; 44: 289-299.
20. Butte NF, Comuzzie AG, Cole SA, et al: Quantitative genetic analysis of the metabolic syndrome in Hispanic children. Pediatr Res 2005; 58: 1243-1248.
21. Burdge GC, Wootton SA: Conversion of alphalinolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr 2002; 88: 411-420.
22. Burdge GC, Jones AE, Wootton SA: Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men. Br J Nutr 2002; 88: 355-363.
23. Pawlosky RJ, Hibbeln JR, Novotny JA, Salem N Jr: Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. J Lipid Res 2001; 42: 1257-1265.
24. Crowe FL, Skeaff CM, Green TJ, Gray AR: Serum n-3 longchain PUFA differ by sex and age in a population-based survey of New Zealand adolescents and adults. Br J Nutr 2008; 99: 168-174.
25. Childs CE, Romeau-Nadal M, Burdge GC, Calder PC: Gender differences in the n-3 fatty acid content of tissues. Proc Nutr Soc 2008; 67: 19-27.
26. Amiano P, Dorronsoro M, De-Renobales M, Ruiz-de-Córdoba JC, Irigoien I, EPIC Group of Spain: Very-long-chain omega-3 fatty acids as markers for habitual fish intake in a population consuming mainly lean fish: the EPIC cohort of Gipuzkoa. Eur J Clin Nutr 2001; 55: 827-832.
27. Bjerve KS, Brubakk AM, Fougner KJ, Johnsen H, Midthjell K, Vik T: Omega-3 fatty acids: essential fatty acids with important biological effects, and serum phospholipid fatty acids as markers of dietary a3-fatty acid intake. Am J Clin Nutr 1993; 57(suppl):801S- 806S.
28. Saadatian-Elahi M, Slimani N, Chajes V, et al: Plasma phospholipid fatty acid profiles and their association with food intakes: results from a cross-sectional study within the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 2009; 89: 331-346.
29. Volek JS, Phinney SD, Forsythe CE, et al: Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet. Lipids 2008; 102: 1413-1417.
30. Forsythe CE, Phinney SD, Fernandez ML, et al: Comparison of low fat and low carbohydrate diets on circulating fatty acid composition and markers of inflammation. Lipids 2008; 43: 65-77.
31. Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Physiol 1959; 37:911-917.
32. Okada T, Furuhashi N, Kuromori Y, Miyashita M, Iwata F, Harada K: Plasma palmitoleic acid content and obesity in children. Am J Clin Nutr 2005; 82: 747-750.
33. Steffen LM, Vessby B, Jacobs DR, et al: Serum phospholipid and cholesteryl ester fatty acids and estimated desaturase activities are related to overweight and cardiovascular risk factors in adolescents. Int J Obes 2008; 32: 1297-1304.
34. Phinney SD: Arachidonic acid maldistribution in obesity. Lipids 1996; 31:S271-S274.
35. Brenner RR: Regulatory function of delta-6- desaturase - key enzyme of polyunsaturated fatty acids synthesis. Adv Exp Med Biol 1977; 83: 85-101.
36. Brenner RR: Nutritional and hormonal factors influencing desaturation of essential fatty acids. Prog Lipid Res 1981; 20: 41-47.
37. De Tomas, Mercuri O, Rodrigo A: Effects of dietary protein and EFA deficiency of liver delta-5, delta-6 and delta-9 desaturase activities in the early developing rat. J Nutr 1980; 110: 595-599.
38. Phinney SD, Tang AB, Thurmond DC, Nakamura MT, Stern JS: Abnormal polyunsaturated lipid metabolism in the obese Zucker rat, with partial metabolic correction by gamma-linolenic acid administration. Metabolism 1993; 42: 1127-1140.
39. Shils M, Shike M, Ross A, Caballero B, Cousins R: Modern Nutrition in Health and Disease, ed 10. Baltimore, Lippincott Williams and Wilkins, 2006.
40. Senanayake S, Brownrigg LM, Panicker V, et al: Monocyte-derived macrophages from men and women with type 2 diabetes mellitus differ in fatty acid composition compared with non-diabetic controls. Diabetes Res Clin Pract 2007; 75: 292-300.
41. Brown JK, Chung S, Sawyer JK, et al: Inhibition of stearoyl-coenzyme A desaturase 1 dissociates insulin resistance and obesity from atherosclerosis. Circulation 2008; 118: 1467-1475.
42. Paillard F, Catheline D, Duff FL, et al: Plasma palmitoleic acid, a product of stearoylcoA desaturase activity, is an independent marker of triglyceridemia and abdominal adiposity. Nutr Metab Cardiovasc Dis 2008; 18: 436-440.
43. Warensjö E, Ohrvall M, Vessby B: Fatty acid composition and estimated desaturase activities are associated with obesity and lifestyle variables in men and women. Nutr Metab Cardiovasc Dis 2006; 16: 128-136.
44. Stefan N, Peter A, Cegan A, et al: Low hepatic stearoyl-CoA desaturase 1 activity is associated with fatty liver and insulin resistance in obese humans. Diabetologia 2008; 51: 648-656.
45. Kunesová M, Hainer V, Tvrzicka E, et al: Assessment of dietary and genetic factors influencing serum and adipose fatty acid composition in obese female identical twins. Lipids 2002; 37: 27-32.
46. Nettleton J, Katz R: N-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review. J Am Diet Assoc 2005; 105: 428-440.
47. Bakewell L, Burdge GC, Calder PC: Polyunsaturated fatty acid concentrations in young men and women consuming their habitual diets. Br J Nutr 2006; 96: 93-99.